To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Critical Care ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Treatment of urea cycle disorders.Enzyme. 1987; 38: 242-250
- Mammalian urea cycle enzymes.Annu Rev Genet. 1986; 20: 431-464
- Inborn errors of the urea cycle.Br J Hosp Med. 1987; 38: 176-183
- Disorders of the urea cycle.Hosp Pract. 1985; 20: 65-72
- Inborn errors of urea synthesis.Ann Neurol. 1994; 35: 133-141
- Hyperammonemia.Curr Probl Pediatr. 1984; 14: 1-69
- Urea cycle disorders: diagnosis, pathophysiology, and therapy.Adv Pediatr. 1996; 43: 127-170
- Current strategies for the management of neonatal urea cycle disorders.J Pediatr. 2001; 138: S30-S39
- Valproate-induced hyperammonemia.Ann Neurol. 1982; 11: 319-321
- Secondary hyperammonemia: a possible mechanism for valproate encephalopathy.Lancet. 1980; 1: 1310-1311
- Valproate-associated hepatotoxicity and its biochemical mechanisms.Med Toxicol Adverse Drug Exp. 1988; 3: 85-106
- [Hyperammonemia in valproate therapy in children and adolescents].Nervenarzt. 1986; 57 ([German]): 314-318
- [Cerebral edema with hyperammonemia in valpromide poisoning. Manifestation in an adult, of a partial deficit in type I carbamylphosphate synthetase].Presse Med. 1988; 17 ([French]): 2063-2066
- Hyperaminoacidemia in epileptic children treated with valproic acid.Childs Nerv Syst. 1990; 6: 434-436
- Ammonia induced encephalopathy from valproic acid in a bipolar patient: case report.Int J Psychiatry Med. 2003; 33: 91-96
- Heterozygote ornithine transcarbamylase deficiency presenting as symptomatic hyperammonemia during initiation of valproate therapy.Neurology. 1992; 42: 666-668
- Hyperamino-acidaemia and hyperammonemia in epileptic children treated with valproic acid.Eur J Pediatr. 1988; 148: 267-269
- Deepening coma in an epileptic patient: the missing link to the urea cycle. Hyperammonaemic metabolic encephalopathy.Nephrol Dial Transplant. 2002; 17: 1351-1353
- Carbamyl phosphate synthetase-1 deficiency discovered after valproic acid-induced coma.Acta Neurol Scand. 1992; 86: 275-279
- Valproic acid-induced hyperammonemia in mentally retarded adults.Neurology. 1984; 34: 550-553
- Postpartum coma and death due to carbamoyl-phosphate synthetase I deficiency.Ann Intern Med. 1994; 120: 216-217
- Hyperammonemia in a patient with short bowel syndrome and chronic renal failure.Nephron. 1996; 72: 693-695
- Chronic vomiting in a case of citrullinaemia detected after treatment by total parenteral nutrition.Gut. 1984; 25: 531-533
- Hyperammonemic coma due to parenteral nutrition in a woman with heterozygous ornithine transcarbamylase deficiency.Gastroenterology. 1995; 109: 282-284
- Ornithine transcarbamylase deficiency unmasked because of gastrointestinal bleeding.J Clin Gastroenterol. 2001; 32: 340-343
- Syndrome of idiopathic hyperammonemia after high-dose chemotherapy: review of nine cases.Am J Med. 1988; 85: 662-667
- Idiopathic hyperammonemia: a frequently lethal complication of bone marrow transplantation.Bone Marrow Transplant. 1996; 17: 1119-1125
- Hyperammonemia following allogeneic bone marrow transplantation.Am J Hematol. 1991; 38: 140-141
- Influence of steroids on urea-cycle enzymes in chronic human liver disease.Klin Wochenschr. 1978; 56: 291-295
- Inhibition of ureagenesis by valproate in rat hepatocytes: role of N-acetylglutamate and acetyl-CoA.Biochem J. 1983; 216: 233-236
- Valproate-induced inhibition of urea synthesis.Lancet. 1987; 1: 48
- Environmentally determined genetic expression: clinical correlates with molecular variants of carbamyl phosphate synthetase I.Mol Genet Metab. 2004; 81: S12-S19
- Increased prevalence of the HFE C282Y hemochromatosis allele in women with breast cancer.Cancer Epidemiol Biomarkers Prev. 2004; 13: 205-212
- Sodium benzoate and arginine: alternative pathway therapy in inborn errors of urea synthesis.Prog Clin Biol Res. 1983; 127: 69-83
- Evidence of lack of toxicity of sodium phenylacetate and sodium benzoate in treating urea cycle enzymopathies.J Inherit Metab Dis. 1981; 4: 231
- Treatment of hyperammonemic coma caused by inborn errors of urea synthesis.J Pediatr. 1980; 97: 893-900
- New pathways of nitrogen excretion in inborn errors of urea synthesis.Lancet. 1979; 2: 452-454
- Phenylacetylglutamine may replace urea as a vehicle for waste nitrogen excretion.Pediatr Res. 1991; 29: 147-150
- Effects of hyperammonaemia on brain function.J Inherit Metab Dis. 1998; 21: 6-20
- Magnetic resonance spectroscopy shows increased brain glutamine in ornithine carbamoyl transferase deficiency.Pediatric Research. 1993; 33: 77-81
- Inhibition of glutamine synthetase reduces ammonia-induced astrocyte swelling in rat.Neuroscience. 1996; 71: 589-599
- Role of ammonia in the pathogenesis of brain edema.Acta Med Okayama. 1986; 40: 313-320
- Hyperammonemia-induced cytotoxic brain edema under osmotic opening of blood-brain barrier in dogs.Research Experimental Medicine. 1985; 185: 425-427
- Adult-onset type II citrullinemia and idiopathic neonatal hepatitis caused by citrin deficiency: involvement of the aspartate glutamate carrier for urea synthesis and maintenance of the urea cycle.Mol Genet Metab. 2004; 81: S20-S26
- Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis (NICCD).J Hum Genet. 2002; 47: 333-341
Article info
Footnotes
Dr. Summar acknowledges the support of NIH grants MOI-RR-0095 and U54-RR-019453.
Complete financial disclosure information for each author is provided in the frontmatter of this supplement on page iii.
Identification
Copyright
© 2005 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
